Clinical trial
Assessing the Cognitive Benefits of Ozanimod and Their Brain-Biomarkers in MS
NCT06334094 is registered in ClinicalTrials.gov with The University of Texas at Dallas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing the Cognitive Benefits of Ozanimod and Their Brain-Biomarkers in MS
- Lead sponsor
- The University of Texas at Dallas
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- June 1, 2024
- Completion date
- May 31, 2028
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.